A Simplified Three‐Tailed N‐Alkyl Phosphoramidate Lipid Platform Enables Inguinal Adipose‐Accumulated mRNA Delivery for Anti‐Obesity Therapy
Advanced Science · 2026-02 · 13 (10)
DOI: 10.1002/advs.202517672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.12.2025. Verfasst von Bin Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, P. R. China. Hauptthemen laut MEDLINE: Obesity, RNA, Messenger, Lipids, Adipose Tissue. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, Beijing Municipal Science & Technology Commission, National Key Research and Development Program of China.
Abstract (Originalsprache)
Obesity is a complex metabolic disorder associated with an increased risk of type 2 diabetes, cardiovascular diseases, and metabolic dysfunction‐associated steatotic liver disease. While protein‐based therapies like glucagon‐like peptide‐1 (GLP‐1) receptor agonists (e.g., semaglutide) and fibroblast growth factor 21 (FGF21) analogs show promise, their clinical utility is limited by poor tissue targeting and the need for frequent high‐dose injections. To overcome these challenges, we develop an mRNA‐based therapy encoding a long‐acting GLP‐1/FGF21 fusion protein (mGLP‐1/FGF21), engineered with an IgG4 Fc domain to enhance stability. For adipose tissue‐specific delivery, we design a three‐tailed N‐alkyl phosphoramidate lipid (NPL) formulation with enhanced fluidity in lipid‐rich microenvironments, promoting membrane fusion and endosomal escape to significantly improve adipocyte transfection efficiency. Systematic optimization reveals that removing DOPE (while retaining cholesterol) enhanced delivery efficiency 5‐fold compared to conventional four‐component Lipid Nanoparticle (LNP), without inducing metabolic burden or inflammation upon repeated dosing. The optimized platform effectively delivers mGLP‐1/FGF21, demonstrating potent anti‐obesity effects in mice through synergistic GLP‐1 and FGF21 signaling. Treatment induces significant reductions in body weight and fat mass while preserving lean mass and ameliorating hepatic steatosis. By combining adipose‐accumulated mRNA delivery with dual‐hormone therapy, this study presents a novel and localized strategy for obesity treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, P. R. China.
- Beijing Key Laboratory of Molecular Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, P. R. China.
- Joint Research Institute of Medical and Pharmaceutical Sciences, Cheeloo College of Medicine, Qilu Hospital of Shandong University, Shandong University, Jinan, P. R. China.
- Peking University-Yunnan Baiyao International Medical Research Center, Beijing, P. R. China.
ORCID-Profile: Lei Miao
Förderung
- Beijing Natural Science Foundation
- Beijing Municipal Science & Technology Commission
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Ma, B., Liu, Y., Zhang, H., Fang, Y., Xue, Y., Xue, J., Jiang, Z., Zhou, T., Hao, Y., Xie, F., & Miao, L. (2026). A Simplified Three‐Tailed N‐Alkyl Phosphoramidate Lipid Platform Enables Inguinal Adipose‐Accumulated mRNA Delivery for Anti‐Obesity Therapy. Advanced Science, 13(10). https://doi.org/10.1002/advs.202517672
Vancouver
Ma B, Liu Y, Zhang H, Fang Y, Xue Y, Xue J, et al. A Simplified Three‐Tailed N‐Alkyl Phosphoramidate Lipid Platform Enables Inguinal Adipose‐Accumulated mRNA Delivery for Anti‐Obesity Therapy. Advanced Science. 2026;13(10). doi:10.1002/advs.202517672
BibTeX
@article{Ma2026,
author = {Ma, Bin and Liu, Yunxuan and Zhang, Huijuan and Fang, Yian and Xue, Yizhe and Xue, Junsheng and Jiang, Ziqiong and Zhou, Tianyan and Hao, Yanyun and Xie, Fei and Miao, Lei},
title = {A Simplified Three‐Tailed N‐Alkyl Phosphoramidate Lipid Platform Enables Inguinal Adipose‐Accumulated mRNA Delivery for Anti‐Obesity Therapy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {10},
doi = {10.1002/advs.202517672}
}
EUVIMED